FDA Advancements in HER2+ Breast Cancer

Video

Recent years have brought many changes to the treatment of patients with HER2-positive metastatic breast cancer.

Recent years have brought many changes to the treatment of patients with HER2-positive metastatic breast cancer.

Related Videos
Colleen O’Leary, DNP, RN, AOCNS, EBP-C, LSSYB, in an interview with Oncology Nursing News.
Michelle H. Johann, DNP, RN, PHN, CPAN, WTA, in an interview with Oncology Nursing News explaining surgical path cards
Alison Tray, of Hartford Healthcare, discusses her team's research on a multidisciplinary team approach to manage the cancer drug shortage
Related Content
© 2024 MJH Life Sciences

All rights reserved.